About
Dr. Gaurav Dixit Gaurav Dixit
Dr. Gaurav Dixit is an Associate Director and Head of Hematology & Bone Marrow Transplant at Paras Hospital, Gurugram. With over 16 years of clinical experience, he has participated in over 500 bone marrow transplants. Trained at CMC Vellore and Mayo Clinic (USA), Dr. Dixit is an expert in treating blood cancers such as leukemia, lymphoma, and multiple myeloma. Notably, he performed Kenya?s first successful bone marrow transplant in 2022.
Specializations
Haematology / Bone Marrow Transplant
Full Profile
Overview & ExpertiseDr. Gaurav Dixit is an accomplished clinical hematologist and bone marrow transplant (BMT) specialist based in Delhi-NCR. Currently practicing as Associate Director of Hemato-Oncology and BMT at Paras Hospital, Gurugram, he possesses over 16 years of experience in managing malignant and non-malignant blood disorders. Dr. Dixit?s core clinical expertise covers autologous and allogeneic stem cell transplantation (including haploidentical and matched unrelated donor transplants), acute and chronic leukemias, multiple myeloma, lymphomas, aplastic anemia, thalassemia major, and pediatric immunodeficiencies.Education & Advanced CredentialsDr. Dixit earned his MBBS and MD in General Medicine from Pt. B.D. Sharma PGIMS, Rohtak. He completed his super-specialty DM in Clinical Hematology at the renowned Christian Medical College (CMC), Vellore?one of Asia's top transplant centers. To refine his skills in plasma cell disorders, he earned a Professional Certificate in Multiple Myeloma from the Mayo Clinic, USA, in 2020.Clinical Milestones & Global ImpactPrior to Paras Hospital, Dr. Dixit served as Unit Head at Artemis Hospital and held key senior consultant positions at Action Cancer Hospital and Max Super Speciality Hospital, Shalimar Bagh, playing an instrumental role in launching their BMT units. In October 2022, Dr. Dixit achieved international acclaim by performing Kenya's first successful bone marrow transplant, helping establish the East African nation's local BMT infrastructure and laboratory facilities. He holds active memberships in the American Society for Transplantation and Cellular Therapy (ASTCT).